David L Becton, MD

Research Program: Cancer Therapeutics Faculty Rank: Professor Campus: Arkansas Children's Hospital College: College of Medicine Department: Pediatrics

Contact Information

• Email Address: BECTONDAVIDL@UAMS.EDU
• Profiles Research Networking Software: View Profile

Publications

• Gill PS, Yu FB, Porter-Gill PA, [et al., including Becton DL]. Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children's Hospital. Journal of personalized medicine. 2021 11(5). PMID: 34064668. PMCID: PMC8150685.
• Mack JM, Pierce CD, Richter GT, [et al., including Becton D]. Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography. Pediatric blood & cancer. 2020:e28824. PMID: 33211399.
• Minard-Colin V, Aupérin A, Pillon M, [et al., including Becton D]. Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children. The New England journal of medicine. 2020 382(23):2207-2219. PMID: 32492302. PMCID: PMC7720281.
• Mack JM, Richter GT, Becton D, [et al.]. Short-term side effects and patient-reported outcomes of bleomycin sclerotherapy in vascular malformations. Pediatric blood & cancer. 2018 65(6):e27008. PMID: 29431255.
• Stine KC, Wahl EC, Liu L, [et al., including Becton DL]. Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicity. Journal of orthopaedic research : official publication of the Orthopaedic Research Society. 2016 34(10):1716-1724. PMID: 26867804. PMCID: PMC5516939.